top of page
Browse by category
Search
Where people shop for their food and the risk of obesity-related cancers
A team of researchers at the University of Connecticut have developed a novel tool to help understand consumer behaviour at the county...
Antag begins trial of AT-7687, a GIPR antagonist designed to address key gaps in obesity treatment
Antag Therapeutics has initiated its first-in-human Phase 1 clinical trial evaluating AT-7687, a first-in-class Glucose-Dependent...
BariPredict: Class II obesity, younger age and concurrent depression are risk factors for eating disorders in potential bariatric patients
Outcomes from the BariPredict cohort have found that 65.8% prevalence of persons at risk of an eating disorder (ED) - opting for, but not...
MC4R Agonist bremelanotide co-administered with tirzepatide meets primary endpoint
Palatin Technologies’ BMT-801 Phase 2 obesity co-administered melanocortin-4 receptor (MC4R) agonist bremelanotide plus glucagon like...
Magnetic bipartition feasible, safe and effective in achieving incisionless, suture/staple-free duodeno-ileostomy
An innovative technique using a biofragmentable magnetic anastomosis system (BMAS) to effect magnetic duodeno-ileostomy (MagDI)...
WL Gore launches Gore SYNECOR preperitoneal biomaterial in Europe, the Middle East and South Africa
WL Gore & Associates (Gore) has announced that GORE SYNECOR Preperitoneal Biomaterial is now available in Europe, Middle East and South...
Journal Watch 2/4/2025
Welcome to our weekly round-up of the latest bariatric and obesity-related papers published in the medical literature. As ever, we have...
Early data shows Revita has potential to prevent weight regain after GLP-1 discontinuation
Fractyl Health has announced positive early data from the open-label REVEAL-1 cohort of its ongoing REMAIN-1 pivotal study. The results...
ENDRA reveals enhanced Strategy to enable the early detection and management of metabolic diseases facilitated by emerging GLP-1 therapies
ENDRA Life Sciences has revealed a new strategic direction to develop and deploy its Thermo-Acoustic Enhanced UltraSound system (TAEUS)...
SUMMIT: Tirzepatide benefits people with obesity, kidney disease and heart failure
Tirzepatide improves kidney function and cardiovascular outcomes among patients with obesity and heart failure with preserved ejection...
Browse by tag
bottom of page